NCT02886793View on ClinicalTrials.gov

Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

August 31, 2018

Conditions
Pulmonary Hypertension
Interventions
DRUG

fludeoxyglucose

All Listed Sponsors
lead

Joan Albert Barbera Mir

OTHER

NCT02886793 - Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects | Biotech Hunter | Biotech Hunter